256 related articles for article (PubMed ID: 23567370)
1. Neuropsychiatric symptoms as risk factors for progression from CIND to dementia: the Cache County Study.
Peters ME; Rosenberg PB; Steinberg M; Norton MC; Welsh-Bohmer KA; Hayden KM; Breitner J; Tschanz JT; Lyketsos CG;
Am J Geriatr Psychiatry; 2013 Nov; 21(11):1116-24. PubMed ID: 23567370
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of neuropsychiatric symptoms in CIND and its subtypes: the Cache County Study.
Peters ME; Rosenberg PB; Steinberg M; Tschanz JT; Norton MC; Welsh-Bohmer KA; Hayden KM; Breitner JC; Lyketsos CG;
Am J Geriatr Psychiatry; 2012 May; 20(5):416-24. PubMed ID: 22522960
[TBL] [Abstract][Full Text] [Related]
3. Neuropsychiatric symptoms in Alzheimer disease and cognitively impaired, nondemented elderly from a community-based sample in Brazil: prevalence and relationship with dementia severity.
Tatsch MF; Bottino CM; Azevedo D; Hototian SR; Moscoso MA; Folquitto JC; Scalco AZ; Louzã MR
Am J Geriatr Psychiatry; 2006 May; 14(5):438-45. PubMed ID: 16670248
[TBL] [Abstract][Full Text] [Related]
4. Progression of cognitive, functional, and neuropsychiatric symptom domains in a population cohort with Alzheimer dementia: the Cache County Dementia Progression study.
Tschanz JT; Corcoran CD; Schwartz S; Treiber K; Green RC; Norton MC; Mielke MM; Piercy K; Steinberg M; Rabins PV; Leoutsakos JM; Welsh-Bohmer KA; Breitner JC; Lyketsos CG
Am J Geriatr Psychiatry; 2011 Jun; 19(6):532-42. PubMed ID: 21606896
[TBL] [Abstract][Full Text] [Related]
5. Neuropsychiatric Symptoms as Risk Factors for Cognitive Decline in Clinically Normal Older Adults: The Cache County Study.
Burhanullah MH; Tschanz JT; Peters ME; Leoutsakos JM; Matyi J; Lyketsos CG; Nowrangi MA; Rosenberg PB
Am J Geriatr Psychiatry; 2020 Jan; 28(1):64-71. PubMed ID: 31186157
[TBL] [Abstract][Full Text] [Related]
6. Association of neuropsychiatric symptoms and sub-syndromes with cognitive impairment in community-dwelling Asian elderly.
Xu X; Ang SL; Hilal S; Chan QL; Wong TY; Venketasubramanian N; Ikram MK; Chen CL
Int Psychogeriatr; 2015 Nov; 27(11):1839-47. PubMed ID: 26201550
[TBL] [Abstract][Full Text] [Related]
7. Neuropsychiatric symptoms and functional status in Alzheimer's disease and vascular dementia patients.
D'Onofrio G; Sancarlo D; Panza F; Copetti M; Cascavilla L; Paris F; Seripa D; Matera MG; Solfrizzi V; Pellegrini F; Pilotto A
Curr Alzheimer Res; 2012 Jul; 9(6):759-71. PubMed ID: 22715983
[TBL] [Abstract][Full Text] [Related]
8. The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease.
Rosenberg PB; Mielke MM; Appleby BS; Oh ES; Geda YE; Lyketsos CG
Am J Geriatr Psychiatry; 2013 Jul; 21(7):685-95. PubMed ID: 23567400
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's disease, and its relationship with cognitive impairment.
M FM; Molano A; Castro J; Zarranz JJ
Curr Alzheimer Res; 2010 Sep; 7(6):517-26. PubMed ID: 20455862
[TBL] [Abstract][Full Text] [Related]
10. Neuropsychiatric symptoms in older people with and without cognitive impairment.
Brodaty H; Heffernan M; Draper B; Reppermund S; Kochan NA; Slavin MJ; Trollor JN; Sachdev PS
J Alzheimers Dis; 2012; 31(2):411-20. PubMed ID: 22571979
[TBL] [Abstract][Full Text] [Related]
11. Vascular risk factors and neuropsychiatric symptoms in Alzheimer's disease: the Cache County Study.
Steinberg M; Hess K; Corcoran C; Mielke MM; Norton M; Breitner J; Green R; Leoutsakos J; Welsh-Bohmer K; Lyketsos C; Tschanz J
Int J Geriatr Psychiatry; 2014 Feb; 29(2):153-9. PubMed ID: 23681754
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging.
Hsiung GY; Sadovnick AD; Feldman H
CMAJ; 2004 Oct; 171(8):863-7. PubMed ID: 15477624
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for neuropsychiatric symptoms in dementia: the Cache County Study.
Steinberg M; Corcoran C; Tschanz JT; Huber C; Welsh-Bohmer K; Norton MC; Zandi P; Breitner JC; Steffens DC; Lyketsos CG
Int J Geriatr Psychiatry; 2006 Sep; 21(9):824-30. PubMed ID: 16955439
[TBL] [Abstract][Full Text] [Related]
14. Neuropsychiatric symptoms, apolipoprotein E gene, and risk of progression to cognitive impairment, no dementia and dementia: the Aging, Demographics, and Memory Study (ADAMS).
Beaudreau SA; Kaci Fairchild J; Spira AP; Lazzeroni LC; O'Hara R
Int J Geriatr Psychiatry; 2013 Jul; 28(7):672-80. PubMed ID: 22927174
[TBL] [Abstract][Full Text] [Related]
15. The association of psychotropic medication use with the cognitive, functional, and neuropsychiatric trajectory of Alzheimer's disease.
Rosenberg PB; Mielke MM; Han D; Leoutsakos JS; Lyketsos CG; Rabins PV; Zandi PP; Breitner JC; Norton MC; Welsh-Bohmer KA; Zuckerman IH; Rattinger GB; Green RC; Corcoran C; Tschanz JT
Int J Geriatr Psychiatry; 2012 Dec; 27(12):1248-57. PubMed ID: 22374884
[TBL] [Abstract][Full Text] [Related]
16. Frequency and subgroups of neuropsychiatric symptoms in mild cognitive impairment and different stages of dementia in Alzheimer's disease.
Siafarikas N; Selbaek G; Fladby T; Šaltytė Benth J; Auning E; Aarsland D
Int Psychogeriatr; 2018 Jan; 30(1):103-113. PubMed ID: 28927477
[TBL] [Abstract][Full Text] [Related]
17. A systematic review of neuropsychiatric symptoms in mild cognitive impairment.
Monastero R; Mangialasche F; Camarda C; Ercolani S; Camarda R
J Alzheimers Dis; 2009; 18(1):11-30. PubMed ID: 19542627
[TBL] [Abstract][Full Text] [Related]
18. Cognitive impairment in the nondemented elderly. Results from the Canadian Study of Health and Aging.
Ebly EM; Hogan DB; Parhad IM
Arch Neurol; 1995 Jun; 52(6):612-9. PubMed ID: 7763211
[TBL] [Abstract][Full Text] [Related]
19. Progression to Dementia or Reversion to Normal Cognition in Mild Cognitive Impairment as a Function of Late-Onset Neuropsychiatric Symptoms.
McGirr A; Nathan S; Ghahremani M; Gill S; Smith EE; Ismail Z
Neurology; 2022 May; 98(21):e2132-e2139. PubMed ID: 35351783
[TBL] [Abstract][Full Text] [Related]
20. Trajectories of neuropsychiatric symptoms over time in healthy volunteers and risk of MCI and dementia.
Leoutsakos JS; Wise EA; Lyketsos CG; Smith GS
Int J Geriatr Psychiatry; 2019 Dec; 34(12):1865-1873. PubMed ID: 31452260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
